Skip to main content

Table 2   Clinical baseline of HCC patients

From: MicroRNA let-7b inhibits cell proliferation via upregulation of p21 in hepatocellular carcinoma

Characteristics Let-7b low (n = 47) Let-7b high (n = 47) P value
Age (years) (mean ± SD) 49.8 ± 9.3 51.8 ± 11.6 0.354
Gender (Male/Female) 40/7 39/8 0.778
HBsAg (positive/negative) 40/7 39/8 0.778
Cirrhosis (positive/negative) 26/21 19/28 0.148
Child–Pugh classification(A/B) 46/1 45/2 0.554
AFP (ng/mL)    0.626
 ≥ 400 35 37  
 < 400 12 10  
Biggest tumor diameter (cm) (mean ± SD) 6.8 ± 4.6 6.0 ± 4.8 0.363
Blood transfusion (positive/negative) 8/39 6/41 0.562
Microvascular invasion (positive/negative) 18/29 17/30 0.831
Portal vein invasion (positive/negative) 4/43 2/45 0.399
Tumor capsule (positive/negative) 9/38 10/37 0.797
BCLC stage    0.779
 A 14 17  
 B 29 27  
 C 4 3